Selexis And Generium Launch Omalizumab Biosimilar In Russia

Xolair Rival Is Third Biosimilar Developed By Firms With SUREtechnology Platform

Russia Map Flag
Selexis and Generium introduce omalizumab in Russia • Source: PSL Images RF / Alamy Stock Photo

More from Biosimilars

More from Products